"In microgravity, there is a very stressful environment that is placed on the body or even cells. And because of that stress, it helps us understand and study diseases at a very fast pace. And it's a really unique environment because when you remove the gravity, the cells form a 3D structure."
On this episode of HYPERSCALE, I am joined by Kimberly Washington, co-founder and Chief Executive Officer of Deep Space Biology, a pioneering company leveraging AI and microgravity research to accelerate health discoveries on Earth.
Deep Space Biology has spent three years collaborating with NASA Gene Lab to standardize 25 years of microgravity research data. Their innovative approach is helping to transform how we study diseases and develop treatments.
Join us as we explore how the unique environment of space accelerates medical research, the development of digital twins for disease modeling, the challenges women face in the space sector, and Kimberly's foundation "Space for Girls" that's empowering the next generation of female space leaders.
FOLLOW ►